Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 5 TO REGISTRATION STATEMENT - ABVC BIOPHARMA, INC. | fs12017a5_americanbrivision.htm |
| EX-5.1 - LEGAL OPINION OF HUNTER TAUBMAN FISCHER & LI, LLC - ABVC BIOPHARMA, INC. | fs12017a_ex5-1americanbriv.htm |
Exhibit 23.1
 |
中正達會計師事務所有限公司 Centurion ZD CPA Limited Certified Public Accountants (Practising) |
HK office: 7th Floor, Nan Dao Commercial Building, 359-361 Queen’s Road Central, Hong Kong
香港 皇后大道中三五九至三六一號 南島商業大廈七樓
Tel : (852) 2851 7954 Fax: (852) 2545 4086
Kowloon office: Room 2105-06, 21/F., Office Tower, Langham Place, 8 Argyle Street, Mongkok, Kowloon, Hong Kong
九龍 旺角 亞皆老街八號 朗豪坊辦公大樓2105-06室
Tel: (852) 2780 0607 Fax: (852) 2780 0013
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of American BriVision (Holding) Corp (the “Company”) on Form S-1/A (Amendment no.5) , of our report dated January 12, 2017 except for Note 2 which was dated at May 22, 2017, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of the Company as of September 30, 2016 and 2015 and for the years then ended, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Centurion ZD CPA Limited
Certified Public Accountants (Practising)
Hong Kong
Dated: September 21, 2017